Fahmy, U.A.; Badr-Eldin, S.M.; Ahmed, O.A.A.; Aldawsari, H.M.; Tima, S.; Asfour, H.Z.; Al-Rabia, M.W.; Negm, A.A.; Sultan, M.H.; Madkhali, O.A.A.;
et al. RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485. Pharmaceutics 2024, 16, 189.
https://doi.org/10.3390/pharmaceutics16020189
AMA Style
Fahmy UA, Badr-Eldin SM, Ahmed OAA, Aldawsari HM, Tima S, Asfour HZ, Al-Rabia MW, Negm AA, Sultan MH, Madkhali OAA,
et al. RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485. Pharmaceutics. 2024; 16(2):189.
https://doi.org/10.3390/pharmaceutics16020189
Chicago/Turabian Style
Fahmy, Usama A., Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, Hibah M. Aldawsari, Singkome Tima, Hani Z. Asfour, Mohammed W. Al-Rabia, Aya A. Negm, Muhammad H. Sultan, Osama A. A. Madkhali,
and et al. 2024. "RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485" Pharmaceutics 16, no. 2: 189.
https://doi.org/10.3390/pharmaceutics16020189
APA Style
Fahmy, U. A., Badr-Eldin, S. M., Ahmed, O. A. A., Aldawsari, H. M., Tima, S., Asfour, H. Z., Al-Rabia, M. W., Negm, A. A., Sultan, M. H., Madkhali, O. A. A., & Alhakamy, N. A.
(2024). RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485. Pharmaceutics, 16(2), 189.
https://doi.org/10.3390/pharmaceutics16020189
